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Equine metabolic syndrome
R. Morgan, J. Keen, C. McGowan
Laminitis is one of the most common and frustrating clinical presentations in equine practice. 
While the principles of treatment for laminitis have not changed for several decades, 
there have been some important paradigm shifts in our understanding of laminitis. Most 
importantly, it is essential to consider laminitis as a clinical sign of disease and not as a 
disease in its own right. Once this shift in thinking has occurred, it is logical to then question 
what disease caused the laminitis. More than 90 per cent of horses presented with laminitis 
as their primary clinical sign will have developed it as a consequence of endocrine disease; 
most commonly equine metabolic syndrome (EMS). Given the fact that many horses will have 
painful protracted and/or chronic recurrent disease, a good understanding of the predisposing 
factors and how to diagnose and manage them is crucial. Current evidence suggests that early 
diagnosis and effective management of EMS should be a key aim for practising veterinary 
surgeons to prevent the devastating consequences of laminitis. This review will focus on EMS, 
its diagnosis and management.
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EquinE metabolic syndrome (EMS) has been defined as the 
presentation of a phenotype of obesity, insulin resistance and 
laminitis or a predisposition to laminitis in equids (Frank and others 
2010). Obesity is defined as increased regional (eg, cresty neck) or 
generalised adiposity. insulin resistance is characterised by basal 
hyperinsulinaemia and/or an excessive insulin response to intravenous 
or oral glucose challenge (insulin dysregulation). Laminitis is defined 
as that occurring in the absence of recognised inflammatory causes, 
such as grain overload, colic and metritis, and non-weight bearing 
causes such as fracture.
it is important to look at what each of these components really 
mean in equids. Obesity is a risk factor, insulin resistance is central 
to the pathophysiology of the disease while laminitis is the resultant 
clinical effect. Obesity on its own does not mean a horse has EMS; 
demonstration of insulin resistance and laminitis (or a predisposition 
to laminitis) is required to demonstrate EMS. 
How common is EMS?
Despite a growing interest in EMS there is little epidemiological 
data on its prevalence, possibly due to the difficulties in defining a 
clinical case. The prevalence of the individual components of EMS 
Review
are, however, easier to evaluate. Obesity prevalence is estimated at 
between 19 and 40 per cent in domesticated populations (Wyse and 
others 2008, Stephenson and others 2011, Thatcher and others 2012), 
while hyperinsulinaemia is found in between 22 and 29 per cent 
of susceptible equine populations (Muno and others 2009, Morgan 
and others 2014b). The prevalence of laminitis solely attributable to 
EMS is unknown, since studies tend to report all forms of laminitis 
together with a wide variation in prevalence estimates (1.5 and 34 
per cent) (Wylie and others 2011). Endocrinopathic laminitis, which 
encompasses EMS and pituitary pars intermedia dysfunction (PPiD), 
has been reported to account for up to 89 per cent of primary laminitis 
cases in one hospital; 66 per cent of these were diagnosed with EMS 
(Karikoski and others 2011). it is clear from these studies that the 
components of EMS are highly prevalent, resulting in a large number 
of ‘at risk’ individuals. 
The role of obesity in EMS
Obesity is defined by the World Health Organization as abnormal or 
excessive fat accumulation that may impair health. Obesity has been 
associated with increased morbidity and mortality in horses (Geor 
2008) and is increasingly recognised as a welfare concern (Owers and 
Chubbock 2013). 
Obesity is the main known risk factor for EMS. Adipose tissue 
is an active endocrine organ secreting adipokines (eg, leptin and adi-
ponectin) and adipose-derived cytokines (eg, tumour necrosis factor 
[TnF]α, interleukin [iL]-1) which can have adverse local and sys-
temic effects. Although the precise mechanisms by which insulin 
resistance develops in obesity has yet to be elucidated, a substantial 
body of work on the subject in rodent models and people has shown 
that when adipose stores are high, a combination of local and remote 
inflammation, dysregulated local glucocorticoid metabolism, oxida-
tive damage, lipid overspill and alterations in the release and action of 
adipokines combine to impair insulin signalling within fat and muscle 
such that organism-wide insulin resistance develops (Kahn and Flier 
2000, Kahn and others 2006, Tomlinson and others 2008). There is 
also evidence in people that different adipose deposits have different 
metabolic functions, such that the pattern of obesity may be as impor-
tant as the degree of obesity; for example, central obesity in people is 
strongly associated with an increased cardiovascular risk (Kannel and 
others 1991). 
OPEN ACCESS
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A small number of studies have attempted to tease out the pos-
sible role of fat in the development of EMS (Burns and others 2010). 
in horses, excess visible fat deposition occurs most commonly in the 
region of the neck crest and rump (Fig 1). Some researchers have sug-
gested that neck crest adipose tissue is more active than omental 
adipose in horses, but the data are not conclusive (Burns and others 
2010).
Insulin resistance and its role in EMS
insulin resistance is the failure of tissues to adequately respond to 
circulating insulin and thus control the blood glucose concentration. 
insulin resistance can be classified as compensated or uncompensated. 
Compensated insulin resistance refers to a state in which the 
pancreas responds to peripheral resistance by producing more 
insulin in combination with decreased insulin clearance, resulting 
in hyperinsulinaemia (De Graaf-Roelfsema 2014). uncompensated 
insulin resistance refers to pancreatic exhaustion, whereby the 
pancreas is no longer able to produce enough insulin and glucose 
control is poor; that is, type 2 diabetes. Horses most commonly 
have compensated insulin resistance and rarely develop pancreatic 
exhaustion and type 2 diabetes (Durham and others 2009).
Compensated insulin resistance is a key feature of the patho-
physiology of EMS. Affected horses and ponies demonstrate resting 
hyperinsulinaemia and/or the development of marked hyperinsu-
linaemic responses to carbohydrate challenge (intravenous or oral 
glucose challenge), collectively described as insulin dysregulation 
(Frank and Tadros 2014). The role of the enteroinsular axis and 
the direct effects of ingested carbohydrates on intestinal incretin 
production are also under increasing scrutiny as an important part 
of the pathophysiology and a potential diagnostic tool (De Graaf-
Roelfsema 2014). in addition, hyperinsulinaemia itself may also 
drive or worsen insulin resistance, possibly by down-regulation of 
insulin receptors or alterations in clearance (Del Prato and others 
1994, Shanik and others 2008). 
Sustained hyperinsulinaemia is associated with many adverse 
effects of metabolic syndrome in people, predominantly related to 
vascular dysfunction, and remains central to the pathophysiology 
of resultant cardiovascular disease. in horses, basal unfasted hyper-
insulinaemia has been associated with susceptibility to laminitis in 
pastured ponies (Treiber and others 2006), and a predictor of incipi-
ent pasture-associated laminitis in ponies (Carter and others 2009). 
Laminitis could be predicted by any three of the following four 
criteria: a body condition score of 7 or more, a cresty neck score 
of 4 or more, basal insulin over 32 µiu/ml, leptin of over 7.3 ng/
ml; however basal insulin alone (>32 µiu/ml) predicted laminitis as 
accurately as the combination of criteria (Carter and others 2009). 
Experimentally, laminitis can be induced by insulin infusion induc-
ing hyperinsulinaemia for an average of 48 to 55 hours (Asplin and 
others 2007, De Laat and others 2010), or by the induction of hyper-
glycaemia along with a lower concentration of endogenous insulin 
(200 µiu/ml) over a similar time period (De Laat and others 2012).
Laminitis and EMS
Laminitis can be viewed as the vascular dysfunction consequence 
of metabolic syndrome in the horse (Katz and Bailey 2012). The 
primary insult to the hoof in EMS is most likely due to alteration in 
the form and function of the vasculature, rather than inflammation, 
in contrast with laminitis secondary to systemic inflammatory 
response syndrome. How this primary insult occurs is unclear, but 
high insulin concentrations may affect blood vessel tone, resulting 
in an altered blood supply to the hoof (Venugopal and others 2011, 
2014, Keen and others 2012). There is also some evidence to suggest 
that insulin may have a direct effect on the epidermal cells of the 
lamellar tissue via insulin-like growth factor signalling pathways 
(De Laat and others 2013).
Histological studies have shown that naturally occurring endo-
crinopathic laminitis differs from that reported in inflammatory 
models, in particular that the rapid devastating disruption of the 
basement membrane seen in inflammatory models does not occur 
in endocrine models or naturally occurring disease (Karikoski and 
others 2014a, b). Although elongation, altered keratinisation and 
disruption of the lamellar-hoof wall junction remains the most 
severe outcome, most cases of endocrinopathic laminitis were asso-
ciated with a prolonged subclinical phase with histological and gross 
changes (predominantly laminitic rings and separation of the white 
line and cap horn production) without a clinical history of pain 
(Karikoski and others 2014a). Horses and ponies with hyperinsu-
linaemia and a relatively recent bout of laminitis showed gross and 
histological lesions consistent with laminitis indistinguishable from 
those that had laminitis for years. However, breed- and age-matched 
control ponies and horses without hyperinsulinaemia had no lesions 
(Karikoski and others 2014a). This supports the theory that equids 
with underlying metabolic syndrome can have painful or non-pain-
(b)
FIG 1: Obesity (a) is the main known risk factor for equine metabolic syndrome, and 
in horses excess visible fat deposition occurs most commonly in the region of the 
neck crest (b) and rump (c)
(a)
(c)
group.bmj.com on November 25, 2015 - Published by http://veterinaryrecord.bmj.com/Downloaded from 
August 15, 2015 | Veterinary Record | 175
ResearchResearch
ful bouts of laminitis for many years before diagnosis and that, if 
underlying metabolic syndrome remains unmanaged, recurrence of 
laminitis is likely. Other research has shown that horses that have 
had laminitis previously are more likely to have further bouts (Wylie 
and others 2013), which emphasises the notion that diagnosis and 
management of EMS before laminitis develops is key to preventing 
chronic, recurrent laminitis. 
Genetic predisposition in EMS
Published cases of EMS have largely occurred in British native 
breeds. This is supported by Finnish research that found that cases 
of primary endocrinopathic laminitis were more likely to occur in 
British native ponies compared to nordic ponies, cold-blooded horses 
and warm- and hot-blooded horses (Karikoski and others 2011). 
Breed differences in insulin sensitivity have been demonstrated, 
where ponies and Andalusian-cross horses showed reduced insulin 
sensitivity compared to standardbred horses (Bamford and others 
2014), and it may be that their metabolic differences solely account 
for the predisposition to EMS. it is likely that EMS is a multifactorial 
disease with complex genetic and environmental interactions at play 
(McCue and others 2015). 
Diagnosing EMS
Clinical evaluation
A tentative diagnosis of EMS may be made in horses that are 
clinically obese, of a predisposed breed and suffering from laminitis. 
Obesity and history of laminitis, or hoof changes indicative of 
earlier episodes should be documented and insulin resistance 
confirmed. The challenge remains to diagnose EMS before the 
onset of laminitis. To achieve this, evaluation of insulin regulation 
in susceptible breeds, especially those that are obese, offers essential 
information for assessing laminitis risk, monitoring progress and 
guiding intervention (Karikoski and others 2014b, Morgan and 
others 2014a).
Body condition scoring (BCS) systems are the most frequently 
used method of defining equine obesity given the limited availabil-
ity of weigh bridges and difficulties in defining obesity in terms of 
bodyweight in a species with so much breed variation. A score of 
4 or 5 out of 5 (Carroll and Huntington 1988) or 7 or more out of 
9 (Henneke and others 1983) are often used as cut-offs for defining 
equine obesity. However, these scoring systems have significant lim-
itations in true estimation of body fat, with horses with BCS over 
5/9 having a nonlinear relationship between BCS and total body 
fat (Dugdale and others 2011). irrespective of the scoring system, 
there are also limitations in owner application (Stephenson and oth-
ers 2011), and owners have been shown to underestimate the BCS 
of their animals even using very simple systems (ireland and oth-
ers 2012). Simple, objective and repeatable adjunctive tools, such as 
body girth measurements, may offer a more accurate estimation of 
body fat in moderate-to-obese horses (Dugdale and others 2011), and 
may be more widely used in the future. Assigning a score to the neck 
crest can also be useful in recognising horses with regional obesity 
(Carter and others 2009).
it is very important that veterinary surgeons recognise subclini-
cal laminitis, but this can be challenging. Visible changes to the hoof 
wall, such as divergent or ‘laminitic’ rings, may indicate previous 
episodes of laminitis, and are closely associated with histological 
lesions (Karikoski and others 2014b). Reduced concavity of the sole, 
dropped soles, a widened white line and presence of cap horn are all 
other potential indicators of subclinical laminitis. Farriers may be 
able to pick up these horn changes more readily than owners. 
if PPiD is suspected (in horses of ≥15 years of age, clinical signs 
may include hypertrichosis/delayed haircoat shedding, abnormal 
adiposity and laminitis), then a basal adrenocorticotropic hormone 
(ACTH) test or dynamic testing, such as a thyrotropin-releasing hor-
mone stimulation test, should be carried out (Durham and others 
2014). it is still vital to evaluate insulin regulation in horses with 
PPiD as insulin dysregulation is likely to be the common risk fac-
tor for laminitis and may explain why some horses with PPiD get 
laminitis frequently and others do not (Morgan and others 2014a, 
Karikoski and others 2015).
 
Assessment of insulin regulation
Basal measurements
Haematology and serum biochemistry are rarely altered in EMS. 
Triglycerides may be mildly elevated in some cases and are correlated 
with serum insulin concentrations (Morgan and others 2014b). 
Basal glucose is rarely elevated due to the rarity of uncompensated 
insulin resistance, as previously discussed.
Basal insulin measurements are an important aid in the diagno-
sis of EMS, while also offering valuable information for monitoring 
progress, assessing laminitic risk and guiding interventions. While 
it is possible to detect insulin resistance in horses by demonstrating 
basal hyperinsulinaemia, false negatives may occur. in our experi-
ence, false positives are less common than false negatives. Basal 
insulin concentrations will be increased by feeding concentrates, 
although they are generally unaffected by low-medium, non-struc-
tural carbohydrate (nSC) roughage (eg, soaked hay or hay with low 
to moderate nSC) (Borgia and others 2011). Physiological stress in 
the form of acute exercise or pain will generally decrease insulin con-
centrations in horses, most likely attributable to increases in circulat-
ing catecholamines that inhibit insulin (Gordon and others 2007). 
Contrary to popular belief, there is no evidence to suggest that pain 
(eg, associated with laminitis) increases basal insulin. Pain in people 
does reduce glucose uptake, but does not affect basal insulin concen-
trations (Greisen and others 2001). Pain and illness, however, will 
increase basal ACTH concentrations (Towns and others 2010), and 
potentially affect a diagnosis of PPiD.
The original cut-off values for insulin and laminitis risk of over 
20 µiu/ml were derived from pastured ponies held in yards for one to 
three hours before testing (Treiber and others 2006, Carter and oth-
ers 2009). Despite this, it has been recommended that the basal insu-
lin be measured following approximately six hours of fasting (Frank 
and others 2010). The authors suggest prolonged fasting is unneces-
sary and that horses should be sampled in the morning before any 
supplementary feeding and having been allowed access to preferably 
low nSC or soaked hay (rather than grazing) overnight. it is vital 
that the preparations undertaken before testing remain the same if 
tests are repeated.
For the purposes of determining serum insulin concentrations, the 
majority of uK laboratories use immunoassay techniques. The most 
commonly used is the immulite 2000, which has been compared 
with the radioimmunoassay (Coat-a-Count; Siemens) and showed 
a good correlation, especially around the levels of diagnostic signifi-
cance (A. E. Durham, personal communication, H. B. Carslake and 
others, unpublished data). if other assays are used, reference intervals 
may be different from the literature and need to be validated.
Proxies (insulin-sensitivity indices) calculated from insulin and 
glucose measurements estimate insulin sensitivity and pancreatic 
response (Muniyappa and others 2008). The two most common 
proxies used are: RiSqi, the reciprocal of the square root of insulin, a 
measure of insulin sensitivity; and MiRG, the modified insulin ratio 
to glucose representing the ability of the pancreas to secrete insulin. 
Given these proxies are generated from basal measurements they are 
subject to similar limitations. However, as proxies convert non-linear 
values to linear values they may be more useful for monitoring over 
time than raw values.
if basal hyperinsulinaemia is not present and yet the phenotype 
of the horses strongly suggests EMS then dynamic testing should be 
undertaken.
Dynamic testing
Dynamic testing gives a more complete picture of the insulin-
glucose dynamics and, although the ideal test has not yet been 
determined, dynamic tests are more sensitive than basal tests (Frank 
and others 2010). Several intravenous tests that can be performed 
in the field have been developed, including the intravenous insulin 
response test (Bertin and Sojka-Kritchevsky 2013) and the combined 
glucose-insulin tolerance test (CGiT) (Eiler and others 2005). 
The CGiT (Fig 2) is currently the recommended test for insulin 
sensitivity in clinical cases (Frank and others 2010), and has also 
been used in recent research studies on EMS (McGowan and others 
2013, Morgan and others 2015). Measured insulin concentrations 
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have been shown to be more repeatable than glucose concentrations 
(Bröjer and others 2013), and thus may be preferred for follow-up 
of cases. 
Other intravenous techniques, such as minimal model analysis, 
require frequent sampling following intravenous glucose and insu-
lin, and computer modelling is used to generate measures of insulin 
sensitivity (Kronfeld and others 2005). This type of testing has been 
shown to have good correlation with clamping techniques, but is 
generally confined to the research setting.
unlike intravenous dynamic testing, the oral glucose test (OGT) 
or oral sugar test (OST) determine the postprandial insulin response 
and include the response of gastrointestinally derived hormones (the 
enteroinsular axis), rather than whole-body insulin sensitivity or 
resistance. Glucose/dextrose is administered at 0.5 to 1 g/kg with a 
small feed, and insulin is measured two hours postprandially (OGT) 
(Liphook Veterinary Laboratory, personal communication), or 150 
mg/kg corn syrup may be administered directly into the mouth via 
a syringe and a blood sample collected for insulin 60 to 90 minutes 
later (OST) (Schuver and others 2014). insulin over 85 µiu/ml (OGT) 
or over 60 µiu/ml (OST) would be considered diagnostic of EMS 
(Liphook Veterinary Laboratory, personal communication). The 
OST compares favourably to the intravenous glucose tolerance test, 
but has not been evaluated against the 
CGiT (Schuver and others 2014). There 
are definite advantages to these tests in 
terms of the simplicity of the test, condu-
cive to field use, but they have yet to be 
fully validated. 
 
Referral/specialist evaluation
Referral can play an important role 
in the diagnosis and management of 
difficult or equivocal cases of EMS or 
endocrinopathic laminitis. A referral 
centre may be able to carry out dynamic 
testing more easily and help in diagnosis 
of more complicated or equivocal cases. 
Additional blood parameters, such as 
triglycerides, leptin and iL-6 may be 
helpful in equivocal cases and may well 
become more commonplace as our 
understanding of the disease improves 
(Pleasant and others 2013, Basinska and 
others 2015).
Treatment of EMS
Management of EMS in horses is based 
on a programme of dietary modifications 
and exercise. Reducing caloric intake 
and increasing energy expenditure are 
the mainstays for reducing obesity 
and improving insulin sensitivity. The 
primary goal is improvement in insulin 
sensitivity, measured as a reduction in 
basal hyperinsulinaemia and insulin 
response to oral or intravenous glucose 
challenge. Research has shown weight 
reduction in horses results in improved 
insulin sensitivity (ungru and others 
2013,  Morgan and others  2015) . 
Veterinary involvement is a key element 
in achieving owner compliance and 
significant weight loss, with good owner 
compliance improvements in CGiT 
results being seen within six to eight 
weeks (Morgan and others 2015). 
Diet
Dietary modification is the key to 
inducing weight loss in the majority 
of horses with EMS. it is essential 
to obtain a detailed history from the 
owner regarding the current feeding 
regimen and management of the horse, 
including options for grazing, exercise 
and confinement. Tailoring the diet to 
the individual needs of the horse leads 
to, very importantly, improved owner 
compliance and results in a better response 
to treatment (Morgan and others 2015). 
The first step is to remove any con-
centrate feed from the diet, as well as any 
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FIG 2: (a) Glucose and (b) insulin response to the combined glucose-insulin test in a pony 
before and after successful weight loss due to dietary management. The night before testing, 
house the horse in an accustomed environment, pre-place the catheter, feed low non-
structural carbohydrate roughage overnight. Next morning, administer 150 mg/kg glucose 
(eg, for a 500 kg horse, 150 ml of 500 mg/ml [50 per cent] glucose, or 187.5 ml of 400 mg/
ml [40 per cent] glucose), immediately followed by 0.10 units/kg of regular insulin (eg, 0.5 
ml/500 kg horse of 100 iu/ml insulin [Humulin S; Eli-Lilly]). Blood samples for glucose should 
be collected before administration of glucose and tested immediately using a handheld 
glucometer validated for use in the horse (eg, Alphatrak), and then at one, five, 15, 25, 35, 
45, 60, 75, 90, 105, 120, 135 and 150 minutes (Eiler and others 2005, Frank and others 2010). 
Blood samples (plain tube) for insulin should be taken before glucose administration at 45 and 
75 minutes. The interpretation from these tests: Blood glucose concentration should return 
to baseline within 45 minutes and insulin should be less than 100 µiu/ml at 45 minutes and 
back to baseline by 75 minutes (Eiler and others 2005, Frank and others 2010). The test can be 
shortened for field use, with samples taken at 45 and 75 minutes only. Note that very insulin-
sensitive animals may become hypoglycaemic at around 45 minutes. If weakness or muscle 
tremors are observed, offer the animal a small palatable feed
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high sugar treats, such as apples. The diet should be forage based, 
with the aim of feeding low- to medium-nSC forage with less than 
10 per cent nSC content (Frank and others 2010). nSC refers to car-
bohydrates usually found within the seeds and leaves of plants, and 
includes starches and simple sugars. Horses normally eat approxi-
mately 2 to 2.5 per cent (nRC 2007) and ponies up to 5 per cent 
(Argo and others 2012) of their bodyweight as dry matter (DM) in a 
24-hour period when given ad lib access to food. it is recommended 
that to induce weight loss, the horse is fed approximately 1.25 per 
cent of their bodyweight in DM (approximately 1.5 per cent in fresh 
weight for hay of 80 to 85 per cent DM) per 24-hour period. Diets 
of less than 1 per cent of bodyweight DM are not recommended 
because of potential problems with hind gut function, hyperlipae-
mia, protein restriction and stereotypies (McGregor-Argo 2009). 
ideally, the nSC content of the available forage should be deter-
mined to inform recommendations and several feed companies offer 
this service commercially. in the absence of this information, soak-
ing is a simple, and frequently recommended, method of reducing 
the nSC content of hay. Soaking hay in cold water for 60 minutes 
reduces the water soluble sugar content by approximately 30 per 
cent (Watts and Chatterton 2004), although soaking for eight to 16 
hours has been shown to result in reduction of water soluble sug-
ars of up 50 per cent (Longland and others 2011, Mack and others 
2014). Soaking also results in a loss of water soluble macrominer-
als (potassium, sodium, magnesium, calcium and phosphorous), 
which will need to be supplemented (Martinson and others 2012, 
Mack and others 2014). Hay soaking can also result in losses of up 
to 25 per cent DM (Argo and others 2015), so soaking hay should 
only be recommended with higher volumes of feed fed (2 per cent 
of current bodyweight fresh weight or greater), or under strict vet-
erinary guidance. Soaking haylage is not recommended, due to the 
risks of increased bacterial fermentation. A commercial high-quality 
balancer should be given to provide adequate total daily require-
ments of vitamins and minerals. Low calorie balancers often have 
relatively greater protein restriction than caloric restriction and are 
not recommended.
Chaff-based, low-nSC feeds, which are designed to provide low 
nSC and are combined with a complete balancer, are an option in 
horses that do not like soaked hay or for owner convenience, but these 
can be expensive (Dugdale and others 2011).
Achieving weight loss in horses and ponies kept at pasture can 
be difficult and unrewarding as it is impossible to determine caloric 
intake. Often, it is preferable to confine the animal in a stable at the 
start to aid initial weight loss. Many horses and ponies can be returned 
to restricted grazing by using bare fields, sand maneges or by use of 
a grazing muzzle, following improvement or normalisation of their 
CGiT results (Morgan and others 2015). it is important, however, to 
counsel owners about how to fit and manage a grazing muzzle. Strip 
grazing or short periods of access to grass can be counterproductive, as 
ponies that have restricted grazing have been found to rapidly com-
pensate and can ingest almost 50 per cent of their daily DM intake for 
24 hours in just three hours of grazing (ince and others 2011).
Exercise
Exercise not only induces weight loss but also independently 
improves insulin sensitivity in people and animals. Ponies exercised on 
a treadmill for six weeks showed improvement in insulin sensitivity, 
which was maintained even after six weeks of deconditioning 
(Freestone and others 1992). Dietary restriction combined with 
exercise was shown to improve insulin sensitivity in obese insulin 
resistant ponies (ungru and others 2013), although light exercise 
without dietary restriction may not be sufficient (Carter and others 
2010).
Exercise is necessarily limited in horses with EMS if they have 
acute or chronic active laminitis, and could be very detrimental in an 
unstable case. ideally, however, as soon as the horse is comfortable 
off all analgesic/anti-inflammatory medication and has appropriate 
solar support, exercise may begin. The exercise should be tailored 
to the individual animal, taking into account their breed, level of 
fitness and the facilities available to the owner. Starting with short 
periods of exercise on a soft surface, such as a manege, may be ben-
eficial. There is limited evidence as to the best protocol, but exercise 
should progress up to 15 minutes of trotting exercise per day to max-
imise glycogen use (Hodgson and others 1985). The horse should be 
monitored closely for a flare-up of laminitis or increased pain. Even 
though pasture turnout may be insufficient to improve insulin sensi-
tivity (Turner and others 2011), removal of exercise by confinement 
can be a trigger factor for laminitis in EMS horses (Wylie and others 
2013). Therefore, any reductions in exercise should be managed care-
fully by concurrent caloric restriction in EMS horses.
Pharmacological interventions
Metformin is an anti-hyperglycaemic drug used predominantly 
within a dual therapy regimen for treatment of type 2 diabetes or 
prediabetes in people, in whom it is thought to suppress hepatic 
glucose production and indirectly stimulate AMP-activated protein 
kinase, a major regulator of cellular and whole-body energy 
homeostasis. it also appears to have other secondary effects, 
including reducing absorption of glucose from the gut, improving 
blood glucose homeostasis, lipid profile and blood pressure. Previous 
studies showed an improvement in basal measures of insulin 
sensitivity in a small number of insulin resistant horses when 
the drug was administered at a dose of 15 mg/kg (Durham and 
others 2008, Durham 2011). However, the oral bioavailability of 
metformin in horses is reported as only 7.1 per cent in unfed horses 
and 3.9 per cent in fed horses (Hustace and others 2009), and more 
recent research has shown a lack of efficacy of the drug on insulin 
sensitivity in both normal and insulin resistant horses (Tinworth 
and others 2010a, 2012). Recent work indicated some reduction 
in glucose absorption from the small intestine in experimental 
horses treated with metformin (Rendle and others 2013), a finding 
that warrants further investigation. While this may indicate a 
role for metformin in the early stages of laminitis, management 
to reduce carbohydrate absorption, the recommended low-soluble 
carbohydrate diet of such cases, possibly precludes any perceived 
benefit from longer-term drug administration.
Research by Frank and others (2005, 2008a, b) found that euthy-
roid horses that were administered levothyroxine had significant 
weight loss and improvement in insulin sensitivity over eight- and 
48-week periods, with no cardiovascular side effects. These stud-
ies did not, however, control the diet of the horses treated and, as 
such, further work is required to determine an accurate efficacy of 
levothyroxine. it is our recommendation that horses treated with 
levothyroxine should not be confined to a stable, due to the poten-
tial welfare aspects of confinement when administered an activity-
inducing drug.
Thiazolidinediones, such as pioglitazone and rosiglitazone, 
are insulin-sensitising drugs used to treat type 2 diabetes in people. 
There is very little evidence to support the use of these drugs in hors-
es; a recent study using lipopolysaccharide to induce insulin resist-
ance in healthy horses showed that pioglitazone failed to improve 
insulin sensitivity or mitigate the effects of lipopolysaccharide on 
insulin sensitivity (Suagee and others 2011).
The use of nutraceuticals and supplements in EMS has received 
some attention in recent years based on their perceived importance 
in people in management of metabolic syndrome (Tinworth and 
others 2010b). Dietary supplementation with short-chain fructo- 
oligosaccharides (ScFOS) has been shown to increase insulin sensi-
tivity in obese horses without dietary restriction (Respondek and 
others 2011), but no additional insulin-sensitising effects of the 
nutraceutical were seen when dietary restriction was used in com-
bination with ScFOS in a randomised crossover trial (McGowan 
and others 2013). The mechanism of action is unclear, but is likely 
related to enhanced bacterial fermentation in the stomach and colon 
(Respondek and others 2007); further work is required to improve 
our understanding. Chromium has been suggested to improve insu-
lin sensitivity by altering the intracellular signalling pathways initi-
ated by the activated insulin receptor (Hummel and others 2007). 
However, chromium had no effect on weight or insulin sensitiv-
ity in horses when fed for 16 weeks (Chameroy and others 2011). 
Similarly, disappointing results were demonstrated in horses given 
cinnamon or omega-3 fatty acids twice daily for 10 days (Earl and 
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others 2012). L-carnitine was shown to improve glucose tolerance in 
one study (Van Weyenberg and others 2009), but these results could 
not be replicated in further studies (Schmengler and others 2013). 
Conclusion
EMS is an important disease of horses and ponies characterised by 
obesity, insulin resistance and a predisposition to laminitis. Our 
understanding of the underlying mechanisms of the disease is still 
limited, but it is an area of active research. Diagnosis of EMS is 
reliant on demonstrating insulin resistance using basal or dynamic 
testing, as well as recognition of the risk factors, such as obesity 
and breed predisposition. Early identification of at-risk animals 
using tests for basal and dynamic insulin regulation may help to 
prevent the development of laminitis if appropriate management is 
employed. The mainstay for treatment of EMS is weight reduction, 
with a combination of dietary modification and exercise in horses 
without painful or unstable laminitis. 
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